Abstract Details

Title Efficacy of Galcanezumab in Patients Who Failed to Respond to Preventives Previously: Results from EVOLVE-1, EVOLVE-2 and REGAIN Studies

Topic Headache

Presentation(s) S20 - (-)

Poster/Presentation
Number 004

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Qi Zhang, MD, PhD (Eli Lilly and Company) PRESENTER	No disclosure on file
Dustin Ruff	Dustin Ruff has received personal compensation for serving as an employee of Eli Lilly and Company. Dustin Ruff has stock in Eli Lilly and Company.
Eric Pearlman, MD	Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co.
	No disclosure on file
	No disclosure on file

��ɫ��